Most lymphoid organ dendritic cell types are phenotypically and functionally immature

被引:268
作者
Wilson, NS
El-Sukkari, D
Belz, GT
Smith, CM
Steptoe, RJ
Heath, WR
Shortman, K
Villadangos, JA
机构
[1] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia
[2] Cooperat Res Ctr Vaccine Technol, Melbourne, Vic, Australia
关键词
D O I
10.1182/blood-2003-02-0513
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dendritic cells (DCs) have been thought to follow a life history, typified by Langerhans cells (LCs), with 2 major developmental stages: an immature stage that captures antigens in the periphery and a mature stage that presents those antigens in the lymphoid organs. However, a systematic assessment of the maturity of lymphoid organ DCs has been lacking. We have analyzed the maturity of the DC types found in the steady state in the spleen, lymph nodes (LNs), and thymus. The DCs that migrate into the iliac, mesenteric, mediastinal, or subcutaneous LNs from peripheral tissues were mature and therefore could not process and present newly encountered antigens. However, all the other DC types were phenotypically and functionally immature: they expressed low levels of surface major histocompatibility complex class 11 (MHC 11) and CD86, accumulated MHC 11 in their endosomes, and could present newly encountered antigens. These immature DCs could 1346 induced to mature by culture in vitro or by Inoculation of inflammatory stimuli in vivo. Therefore, the lymphoid organs contain a large cohort of immature DCs, most likely for the maintenance of peripheral tolerance, which can respond to infections reaching those organs and mature in situ. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:2187 / 2194
页数:8
相关论文
共 47 条
[1]   Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[2]  
BEIZ GT, 2002, J EXP MED, V196, P1099
[3]   Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[4]   Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo [J].
Brocker, T ;
Riedinger, M ;
Karjalainen, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (03) :541-550
[5]   A novel inhibitory receptor (ILT3) expressed on monocytes, macrophages, and dendritic cells involved in antigen processing [J].
Cella, M ;
Dohring, C ;
Samaridis, J ;
Dessing, M ;
Brockhaus, M ;
Lanzavecchia, A ;
Colonna, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (10) :1743-1751
[6]   Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells [J].
Cella, M ;
Engering, A ;
Pinet, V ;
Pieters, J ;
Lanzavecchia, A .
NATURE, 1997, 388 (6644) :782-787
[7]   Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo [J].
DeSmedt, T ;
Pajak, B ;
Muraille, E ;
Lespagnard, L ;
Heinen, E ;
DeBaetselier, P ;
Urbain, J ;
Leo, O ;
Moser, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (04) :1413-1424
[8]  
ESOUSA CR, 1993, J EXP MED, V178, P509
[9]  
ESOUSA CR, 1999, J IMMUNOL, V162, P6552
[10]  
Finkelman FD, 1996, J IMMUNOL, V157, P1406